Project Grant S15OD042595
- The National Institutes of Health Office of the Director awarded $350,000 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) on September 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to purchase a digital ventilated cage system from Tecniplast for the Behavioral Phenotyping Core vivarium. The DVC system incorporates continuous, real-time monitoring of animal activity and environmental cage parameters including temperature, humidity,...
- The National Institutes of Health Office of the Director awarded Cornell University $349,982 under the Research Infrastructure Programs (CFDA 93.351) on September 1, 2026 to advance germ-free and gnotobiotic mouse husbandry operations at the Cornell Center for Animal Resources and Education. The award funds the acquisition of isolator caging systems and biosafety changing systems designed to maintain sterile germ-free environments for research mice. The isolator systems feature enhanced ports...
- The National Institutes of Health Office of the Director awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $398,640 under Project Grant R24OD039767 on September 1, 2026, to examine the effects of caging density, temperature, and cage-change frequency on the rigor and reproducibility of research conducted with mouse models. The recipient will employ home cage monitoring, video recording, ultrasonic vocalization recording, and telemetry to assess how...
- Federal Project Grant Award Summary The University of California, Los Angeles (UCLA) Rodent Behavioral Testing Core (BTC), in collaboration with the Division of Laboratory Animal Medicine (DLAM), received a $349,189 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to modernize rodent housing and monitoring infrastructure. The award, effective August 1, 2025 through July 31, 2026, funds the acquisition...
- The National Institute of General Medical Sciences, under the Department of Health and Human Services National Institutes of Health, awarded the University of Delaware $392,495 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate mechanisms of extracellular vesicle biogenesis and uptake. The research examines how cells release distinct extracellular vesicle subpopulations and how those vesicles mediate intercellular transport of bioactive...
- The National Institute of General Medical Sciences awarded the University of Delaware $460,953 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate subcellular transport, regulation, and function of RNAs during early development. The research addresses how specific RNAs are transported to the mitotic spindle and what functions proteins encoded by localized transcripts perform during rapid early cleavage divisions in animal embryos. The funded...
- The National Institute of Allergy and Infectious Diseases awarded the University of Delaware $649,728 on August 21, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate lactic acid-mediated protection of the cervicovaginal epithelium against sexually transmitted infections. The research develops and utilizes a microfluidic microphysiological system (MPS) modeling the cervical epithelium to define how lactic acid, produced by optimal resident microbiota...
- The National Institutes of Health Office of the Director awarded A.T. Still University of Health Sciences $131,142 on September 1, 2026 under the Research Infrastructure Programs (CFDA 93.351) to acquire a Lynx Model 310XL cage and bottle washer for the Kirksville College of Osteopathic Medicine animal care facility. The university proposed purchase of the modern, efficient, eco-friendly washer to replace an outdated unit installed in 2010 that can no longer meet the demands of the shared...
- The National Institutes of Health Office of the Director awarded The Trustees of Columbia University in the City of New York $350,000 on September 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to modernize sterilization infrastructure at the Irving Cancer Research Center vivarium. Columbia will replace a bulk steam autoclave with a Gruenberg Steri-Dry bulk dry-heat sterilizer to sterilize cages supporting barrier housing for patient-derived xenografts, immunocompromised and...
- The National Institute of General Medical Sciences awarded the University of Delaware $860,884 on September 15, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to develop novel dynamic material platforms for studying spatiotemporal mechanobiology. The Corbin Lab will design engineered microdevices and materials with tunable mechanical properties to model how cells respond to time-dependent variations in their mechanical environment, including topography,...
The National Institutes of Health Office of the Director awarded the University of Delaware $349,827 on August 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to procure and install individually ventilated caging (IVC) systems and filtered animal handling transfer cabinets at the Life Sciences Research Facility (LSRF) in Newark, Delaware. The LSRF, which serves over 30 principal investigators and multiple NIH-funded programs, has experienced 70 percent growth in animal housing demand over the past five years and currently operates outdated open-top rodent caging systems that pose biosecurity and personnel safety risks. The modernization replaces legacy open-top rodent cages with IVC systems and installs filtered handling cabinets to reduce airborne pathogen transmission, minimize allergen exposure for personnel, and improve animal welfare while enhancing operational efficiency and aligning with Guide for the Care and Use of Laboratory Animals standards. The upgrades will support emerging transgenic rodent research, health sciences, and engineering projects across the university's biomedical research community. The period of performance runs from August 15, 2026, through August 14, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $349.8k | 8/21/26 |